Spacer
Spacer

LATEST NEWS - PHARMA & BIOTECH INDUSTRY

More batches of common hypertension drug taken off the market

Torrent Pharmaceuticals Ltd. is withdrawing more batches of Losartan potassium tablets, USP and Losartan potassium/hydrochlorothiazide tablets, USP.

Posted on 27 September 2019 | 12:00 pm


New drug relieves acute migraine in clinical trial

The results of a large phase III trial show that the novel drug rimegepant can relieve pain and other symptoms of acute migraine with minimal side effects.

Posted on 12 July 2019 | 5:00 pm


Switching off this enzyme reversed prediabetes in mice

A new study shows that deactivating an enzyme that alters ceramides can prevent insulin resistance and fatty liver as well as reverse prediabetes in mice.

Posted on 9 July 2019 | 6:00 pm


How vitamin D helps fight treatment-resistant cancer

Two active forms of vitamin D can kill treatment-resistant cancer cells by blocking a way that the cells pump out chemotherapy drugs, a new study shows.

Posted on 19 June 2019 | 6:00 pm


Why scientists are searching the ocean for new drugs

Medical researchers are increasingly turning their attention to the ocean in their search for new drugs. In this Spotlight, we ask why.

Posted on 8 June 2019 | 9:00 am


What are the side effects and risks of Ritalin?

Ritalin (methylphenidate) is a stimulant medication for the treatment of ADHD and narcolepsy. Ritalin can cause side effects and has the potential for misuse and addiction. Researchers are investigating the long-term safety and effectiveness of this drug in children and adolescents. Learn more here.

Posted on 31 May 2019 | 3:00 am


Synthetic CBD may be a safe treatment for seizures

A nonintoxicating, synthetic CBD that is not easy to convert to THC and comprises inexpensive, noncannabis ingredients treated seizures safely in rats.

Posted on 30 May 2019 | 6:00 pm


What to know about clindamycin

Clindamycin is an antibiotic drug. This article provides an overview of clindamycin, including what it can treat, how much doctors recommend taking, and possible adverse effects and interactions.

Posted on 29 May 2019 | 10:00 pm


Scientists discover anti-aging potential in old drug

The discovery of a second cell target for the immunosuppressant rapamycin could help its development as an anti-aging, neuroprotective drug.

Posted on 29 May 2019 | 6:00 pm


Novel Alzheimer's drug passes first phase of human testing

A drug that tackles toxic protein buildup in Alzheimer's disease in a novel way has passed phase 1 of clinical trials, which tests safety in humans.

Posted on 15 May 2019 | 6:00 pm


button back

Spacer
 
Spacer